γ/δ-T cells for the immunotherapy of pediatric acute lymphoblastic leukemia with blinatumomab
Klinische Pädiatrie · 01.05.2024 · 236 (03) · 203
DOI: 10.1055/s-0044-1786568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von J Dubke und 5 weiteren Autor:innen.
Abstract (Originalsprache)
γ/δ-T cells for the immunotherapy of pediatric acute lymphoblastic leukemia with blinatumomab
Zitieren
APA
Dubke, J., Schattling, B., Bley, I. A., Klokow, M., Müller, I., & Queudeville, M. (2024). γ/δ-T cells for the immunotherapy of pediatric acute lymphoblastic leukemia with blinatumomab. Klinische Pädiatrie, 236(03), 203. https://doi.org/10.1055/s-0044-1786568
Vancouver
Dubke J, Schattling B, Bley IA, Klokow M, Müller I, Queudeville M. γ/δ-T cells for the immunotherapy of pediatric acute lymphoblastic leukemia with blinatumomab. Klinische Pädiatrie. 2024;236(03):203. doi:10.1055/s-0044-1786568
BibTeX
@article{Dubke2024,
author = {Dubke, J and Schattling, B and Bley, I A and Klokow, M and Müller, I and Queudeville, M},
title = {γ/δ-T cells for the immunotherapy of pediatric acute lymphoblastic leukemia with blinatumomab},
journal = {Klinische Pädiatrie},
year = {2024},
volume = {236},
number = {03},
pages = {203},
doi = {10.1055/s-0044-1786568}
}
EUVIMED